LAUSR

Little is known about the association between coronavirus disease 2019 [COVID-19] and autoimmune diseases, especially for systemic lupus erythematosus [SLE]. SLE patients meet with a throng of questions during the pandemic, including minimize the risk of infection, the complex pathological features and cytokine profiles, diagnosis and treatment, rational choice of drugs and vaccine, good nursing and psychological supervision, etc. In this study, we review and discuss the multifaceted effects of the COVID-19 pandemic on patients living with SLE using the available literatures. Cross-talk was existed in implicated inflammatory pathways/mechanisms between SLE and SARS-CoV-2 infection, and SARS-CoV-2 infection shares similarities with SLE in clinical characters and immuno-inflammatory responses. Current epidemiological data inadequate assess the risk and severity of COVID-19 in SLE. More evidences supported that HCQ and CQ unable prevent COVID-19. During the pandemic, patients with SLE had a higher rate of hospitalization. Vaccination helps to reduce the risk of infection. Several therapies for patients with SLE infected COVID-19 were discussed. The cases in the study can provide meaningful information for clinical diagnosis and management. Our mainly aim is to help the prevention and treatment of patients with SLE infected COVID-19.